Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2020-03-23
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT03713372
- Locations
- 🇨🇳
Cancer hospital Chinese academy of medical sciences, Beijing, Beijing, China
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors
- First Posted Date
- 2018-10-02
- Last Posted Date
- 2018-10-02
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 90
- Registration Number
- NCT03692520
- Locations
- 🇨🇳
307 Hospital of PLA, Beijing, Beijing, China
Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer
- First Posted Date
- 2018-10-02
- Last Posted Date
- 2018-10-02
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT03692689
- Locations
- 🇨🇳
Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang, China
Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC
Phase 2
- Conditions
- Interventions
- First Posted Date
- 2018-01-23
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 110
- Registration Number
- NCT03405272
- Locations
- 🇨🇳
The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China
🇨🇳The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
🇨🇳Fujian Cancer Hospital, Fuzhou, Fujian, China
Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A
- First Posted Date
- 2016-10-03
- Last Posted Date
- 2016-10-03
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT02921945
- Locations
- 🇨🇳
Xiangya Hospital of Centre-South University, Changsha, Hunan, China
Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A
- First Posted Date
- 2016-09-02
- Last Posted Date
- 2016-09-02
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT02888223
- Locations
- 🇨🇳
Xiangya Hospital of Centre-South University, Changsha, Hunan, China
A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2016-05-16
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 330
- Registration Number
- NCT02772822
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT02456207
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
Phase 1
- Conditions
- Interventions
- First Posted Date
- 2014-08-07
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT02211443
Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma.
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-08-01
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT02206308
© Copyright 2024. All Rights Reserved by MedPath